Organon And Entelos Have Extended Their Ongoing Rheumatoid Arthritis (RA) Collaboration By Two Years
Tue, 20 Feb 2007 03:00 PM EST
... Organon, the human healthcare business unit of Akzo Nobel and Entelos Inc., a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announced today a two-year extension of their ongoing rheumatoid arthritis (RA) collaboration. Financial terms were not disclosed. [click link for full article] ...
Related Topics
- Rheumatoid Arthritis
- Arthritis
- Juvenile Rheumatoid Arthritis
- Rheumatoid Factor
- Rituximab
- Arthritis, Rheumatoid
- Adalimumab
- Septic Arthritis
- Reactive Arthritis
- Infliximab
- Nandrolone Decanoate Injection
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Réunion
- Etanercept
- Osteoarthritis
- Death And Dying
- Autoimmune Diseases
- Niacin Extended Release
- Lovastatin Extended Release
- Rheumatoid spondylitis

Not Signed In -


